Aberrant DNA methylation in human cancers

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 6, 2013, Pages 798-804

  Li, Wen ^a   Chen, Bi Feng ^b  

^a Hubei Medical College   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

aberrant DNA methylation; epigenetics; human cancers; treatment

Indexed keywords

ARTICLE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; NEOPLASM;

DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; NEOPLASMS;

EID: 84891604059     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1201-0     Document Type: Article

References (69)

1. Esteller M. Cancer epigenetics for the 21st century: What's next? Genes Cancer, 2011,2(6):604-606
2. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis, 2010,31(1):27-36
3. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol, 2005,45:629-656 (Pubitemid 40261820)
4. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev, 2011,25(10):1010-1022
5. Medvedeva YA, Fridman MV, Oparina NJ, et al. Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genomics, 2010,11:48
6. Lan J, Hua S, He X, et al. DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim Biophys Sin (Shanghai), 2010,42(4):243-252
7. Dhe-Paganon S, Syeda F, Park L. DNA methyltransferase 1: regulatory mechanisms and implications in health and disease. Int J Biochem Mol Biol, 2011,2(1):58-66
8. Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 1999,99(3):247-257 (Pubitemid 29519904)
9. Thiagarajan D, Dev RR, Khosla S. The DNA methyltranferase Dnmt2 participates in RNA processing during cellular stress. Epigenetics, 2011,6(1):103-113
10. Suetake I, Shinozaki F, Miyagawa J, et al. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem, 2004,279(26):27 816-27 823 (Pubitemid 38812623)
11. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 2002,21(35):5427-5440 (Pubitemid 34983479)
12. Fournier A, Sasai N, Nakao M, et al. The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Brief Funct Genomics, 2012,11(3):251-264
13. Defossez PA, Stancheva I. Biological functions of methyl-CpG-binding proteins. Prog Mol Biol Transl Sci, 2011,101:377-398
14. Ai T, Cui H, Chen L. Multi-targeted histone deacetylase inhibitors in cancer therapy. Curr Med Chem, 2012,19(4):475-487
15. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol, 2004,22(22):4632-4642 (Pubitemid 41185132)
16. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet, 2010,70:27-56
17. Torano EG, Petrus S, Fernandez AF, et al. Global DNA hypomethylation in cancer: review of validated methods and clinical significance. Clin Chem Lab Med, 2012,50(10):1733-1742
18. Daura-Oller E, Cabre M, Montero MA, et al. Specific gene hypomethylation and cancer: new insights into coding region feature trends. Bioinformation, 2009,3(8):340-343
19. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics, 2009,1(2):239-259
20. Herceg Z, Ushijima T. Introduction: epigenetics and cancer. Adv Genet, 2010,70:1-23
21. Denis H, Ndlovu MN, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep, 2011,12(7):647-656
22. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by micro- RNAs: are the answers in sight? Nat Rev Genet, 2008,9(2):102-114
23. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA, 2007,104(40):15 805-15 810 (Pubitemid 350035380)
24. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 2009,113(25):6411-6418
25. Duursma AM, Kedde M, Schrier M, et al. miR-148 targets human DNMT3b protein coding region. RNA, 2008,14(5):872-877 (Pubitemid 351574909)
26. Braconi C, Huang NY, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology, 2010,51(3):881-890
27. Huang J, Wang Y, Guo Y, et al. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology, 2010,52(1):60-70
28. Pan W, Zhu S, Yuan M, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol, 2010,184(12):6773-6781
29. Zhao S, Wang Y, Liang Y, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum, 2011,63(5):1376-1386
30. Chen BF, Gu S, Suen YK, et al. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer. Epigenetics, 2013,9(1):1-8
31. Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics, 2006,5(10):1799-1810 (Pubitemid 44688189)
32. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol, 2006,16(4):288-302 (Pubitemid 44311043)
33. Li H, Rauch T, Chen ZX, et al. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem, 2006,281(28):19 489-19 500 (Pubitemid 44035453)
34. Esteve PO, Chin HG, Benner J, et al. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA, 2009,106(13):5076-5081
35. Lavoie G, Esteve PO, Laulan NB, et al. PKC isoforms interact with and phosphorylate DNMT1. Bmc Biology, 2011,9:31
36. Ling Y, Sankpal UT, Robertson AK, et al. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res, 2004,32(2):598-610 (Pubitemid 38263051)
37. Kang ES, Park CW, Chung JH. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. Biochem Biophys Res Commun, 2001,289(4):862-868 (Pubitemid 34060084)
38. Lee B, Muller MT. SUMOylation enhances DNA methyltransferase 1 activity. Biochem J, 2009,421(3):449-461
39. Wang J, Hevi S, Kurash JK, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet, 2009,41(1):125-129
40. Glickman JF, Pavlovich JG, Reich NO. Peptide mapping of the murine DNA methyltransferase reveals a major phosphorylation site and the start of translation. J Biol Chem, 1997,272(28):17 851-17 857 (Pubitemid 27311228)
41. Goyal R, Rathert P, Laser H, et al. Phosphorylation of serine-515 activates the mammalian maintenance methyltransferase Dnmt1. Epigenetics, 2007,2(3):155-160 (Pubitemid 350200393)
42. Kameshita I, Sekiguchi M, Hamasaki D, et al. Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun, 2008,377(4):1162-1167
43. Sugiyama Y, Hatano N, Sueyoshi N, et al. The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/epsilon. Biochem J, 2010,427(3):489-497
44. Hervouet E, Lalier L, Debien E, et al. Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One, 2010, 5(6):e11333
45. Niessen HE, Demmers JA, Voncken JW. Talking to chromatin: post-translational modulation of polycomb group function. Epigenetics Chromatin, 2009,2(1):10
46. Rountree MR, Bachman KE, Herman JG, et al. DNA methylation, chromatin inheritance, and cancer. Oncogene, 2001,20(24):3156-3165 (Pubitemid 32553571)
47. Graff JR, Herman JG, Lapidus RG, et al. E-Cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res, 1995,55(22):5195-5199
48. Du W, Searle JS. The rb pathway and cancer therapeutics. Curr Drug Targets, 2009,10(7):581-589
49. Cheng NC, Beitsma M, Chan A, et al. Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus. Oncogene, 1996,13(8):1737-1744 (Pubitemid 26377506)
50. Cheng NC, Chan AJK, Beitsma MM, et al. A human modifier of methylation for class I HLA genes (MEMO-1) maps to chromosomal bands 1p35-36.1. Hum Mol Genet, 1996,5(3):309-317 (Pubitemid 26069574)
51. Wu JJ, Issa JP, Herman J, et al. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of Nih-3t3 cells. Proc Natl Acad Sci USA, 1993,90(19):8891-8895 (Pubitemid 23306416)
52. Vertino PM, Yen RWC, Gao J, et al. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5)- methyltransferase. Mol Cell Biol, 1996,16(8):4555-4565 (Pubitemid 26251257)
53. Rountree MR, Bachman KE, Baylin SB. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet, 2000,25(3):269-277 (Pubitemid 30437311)
54. Kennedy BK, Barbie DA, Classon M, et al. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev, 2000,14(22):2855-2868
55. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev, 2000,14(19):2393-2409
56. Harbour JW, Dean DC. Chromatin remodeling and Rb activity. Curr Opin Cell Biol, 2000,12(6):685-689
57. Sahin M, Sahin E, Gumuslu S, et al. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer Metastasis Rev, 2010,29(4):655-676
58. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell, 1980,20(1):85-93 (Pubitemid 10117303)
59. Goffin J, Eisenhauer E. DNA methyltransferase inhibitors-state of the art. Ann Oncol, 2002,13(11):1699-1716 (Pubitemid 35439450)
60. El-Osta A. Review on epigenetics in cancer gene therapy: series I. Cancer Gene Therapy, 2005,12(8):663-664 (Pubitemid 41045563)
61. Cheng JC, Yoo CB, Weisenberger DJ, et al. Preferential response of cancer cells to zebularine. Cancer Cell, 2004,6(2):151-158 (Pubitemid 39485687)
62. Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, et al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res, 2003,9(5):1596-1603 (Pubitemid 36554581)
63. Yan L, Nass SJ, Smith D, et al. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Therapy, 2003,2(5):552-556
64. Tan J, Yang XJ, Zhuang L, et al. Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev, 2007,21(9):1050-1063 (Pubitemid 46686474)
65. Gal-Yam EN, Saito Y, Egger G, et al. Cancer epigenetics: Modifications, screening, and therapy. Ann Rev Med, 2008,59:267-280 (Pubitemid 351287937)
66. Huang Y, Greene E, Stewart TM, et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA, 2007,104(19):8023-8028 (Pubitemid 47185869)
67. Loh YH, Zhang W, Chen X, et al. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev, 2007,21(20):2545-2557 (Pubitemid 47607666)
68. Decarlo D, Hadden MK. Oncoepigenomics: Making histone lysine methylation count. Eur J Med Chem, 2012,56:179-194
69. Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: Molecular mechanism. Cell Biochem Biophys, 2013,67(2):501-513